Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biomarkers for amyotrophic lateral sclerosis.

Expert review of molecular diagnostics - 1 May 2006

Bowser Robert, Cudkowicz Merit, Kaddurah-Daouk Rima

Abstract excerpt

Amyotrophic lateral sclerosis (ALS) is the most common form of motor neuron disease. ALS is a fatal neurodegenerative disease and clinical diagnosis typically takes many months to complete. Early disease diagnosis through the use of biomarkers may aid in correct clinical management of patients an...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Algorithms
Share to Amyotrophic Lateral Sclerosis
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genomics

Share to Molecular Diagnostic Techniques

Share to Motor Neurons

Share to Muscles

Share to Proteomics

Source

Identifiers

PMID: 16706741
DOI: 10.1586/14737159.6.3.387

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-16706741-2026-09-04.1. Manifest publication-graph-cohort-2026-09-04.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biomarkers for amyotrophic lateral sclerosis.PMID 16706741Read ↗

Multi-Omics for Biomarker Discovery and Target Validation in Biofluids for Amyotrophic Lateral Sclerosis DiagnosisSemantic proximity Read ↗

Proteomic studies in the discovery of cerebrospinal fluid biomarkers for amyotrophic lateral sclerosisSemantic proximity Read ↗

Identification of a presymptomatic and early disease signature for Amyotrophic Lateral Sclerosis (ALS): protocol of the premodiALS studySemantic proximity Read ↗

A plasma proteomics-based candidate biomarker panel predictive of amyotrophic lateral sclerosisSemantic proximity Read ↗

Unveiling amyotrophic lateral sclerosis complexity: insights from proteomics, metabolomics, and microbiomicsSemantic proximity Read ↗

Metabolomics: A Tool to Understand the Impact of Genetic Mutations in Amyotrophic Lateral Sclerosis.Semantic proximity Read ↗

Ensuring continued progress in biomarkers for amyotrophic lateral sclerosisSemantic proximity Read ↗

Disease-related changes in the cerebrospinal fluid metabolome in amyotrophic lateral sclerosis detected by GC/TOFMS.Semantic proximity Read ↗

Studies of Genetic and Proteomic Risk Factors of Amyotrophic Lateral Sclerosis Inspire Biomarker Development and Gene TherapySemantic proximity Read ↗

Peptidomic analysis of CSF reveals new biomarker candidates for amyotrophic lateral sclerosisSemantic proximity Read ↗

Network analysis of the cerebrospinal fluid proteome reveals shared and unique differences between sporadic and familial forms of amyotrophic lateral sclerosisSemantic proximity Read ↗

Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.